Regulation And Legal
Cohance Lifesciences Submits FY26 BRSR Report
Cohance Lifesciences submitted its standalone Business Responsibility and Sustainability Report for FY 2025-26 to BSE and NSE, complying with SEBI Regulation 34(2)(f).
The company reported 95.72% turn
